Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

LED Medical Diagnostics Inc LEDIF

"LED Medical Diagnostics Inc is a Canada based company engaged in development and marketing of a medical device under the trade name VELscope which is used in the dental industry to help identify oral soft tissue abnormalities including those which may be cancerous or precancerous. In addition, the company also features a Digital division that provides dentists and oral health diagnostic imaging products and software. It principally operates in North America."


GREY:LEDIF - Post by User

Comment by Kimsamkeson Oct 11, 2017 8:33am
142 Views
Post# 26798154

RE:LMD - POLAR ASSET MANAGMENT HOLD OVER 17% OF LMD SHARES

RE:LMD - POLAR ASSET MANAGMENT HOLD OVER 17% OF LMD SHARES

ITEM 3 – INTEREST IN SECURITIES OF THE REPORTING ISSUER

  1. 3.1  State the designation and the net increase or decrease in the number or principal amount of securities, and in the eligible institutional investor’s securityholding percentage in the class of securities, since the last report filed by the eligible institutional investor under Part 4 or the early warning requirements.

    Since the last report dated September 8, 2017, there has been a net increase of 1,000,000 Shares over which Polar, on behalf of client accounts over which it has discretionary trading authority, exercised control or direction, representing a net increase of 0.26% of all outstanding Shares.

  2. 3.2  State the designation and number or principal amount of securities and the eligible institutional investor’s securityholding percentage in the class of securities at the end of the month for which the report is made.

    As at September 30, 2017, Polar, on behalf of client accounts over which it has discretionary trading authority, exercised control or direction over 51,000,000 Shares and 18,333,333 warrants (each whole warrant being exercisable for a period of 24 months into one Share at a price of $0.10 per Share), representing approximately 17.68% of the issued and outstanding Shares (assuming conversion of any convertible securities into such Shares).

    The foregoing percentage was calculated based on 373,833,872 Shares outstanding as at August 16, 2017 pursuant to the information set out in the Issuer’s Management Discussion and Analysis for the three and six months ended June 30, 2017 dated as of August 16, 2017. 


<< Previous
Bullboard Posts
Next >>